» Articles » PMID: 15060316

Interaction Between Hypertension, ApoE, and Cerebral White Matter Lesions

Overview
Journal Stroke
Date 2004 Apr 3
PMID 15060316
Citations 76
Authors
Affiliations
Soon will be listed here.
Abstract

Background And Purpose: Cerebral white matter lesions (WMLs) are frequently found on magnetic resonance imaging scans in both cognitively intact and demented elderly persons. Vascular risk factors, especially hypertension, are related to their presence. However, not every person with vascular risk factors has WMLs, which suggests interaction with other determinants, eg, genetic factors. The epsilon4 allele of the apolipoprotein E gene (apoE) may be a candidate because this allele is associated with both the vascular risk factors and the consequences (cognitive impairment, dementia) of WMLs.

Methods: We investigated apoE genotype, blood pressure levels, and their interaction in relation to subcortical and periventricular WMLs in 971 participants in the Rotterdam Scan Study.

Results: ApoE epsilon4 carriers had a significantly higher subcortical WML volume than did apoE epsilon3epsilon3 carriers (adjusted mean difference, 0.5; 95% confidence interval, 0.2 to 0.8), irrespective of hypertension. This was not found for periventricular WMLs. Participants with both hypertension and at least 1 apoE epsilon4 allele had the highest degree of both types of WML; the interaction was statistically significant for subcortical WMLs (P=0.016).

Conclusions: apoE epsilon4 carriers are at increased risk for WMLs if they suffer from hypertension as well. This may reflect a diminished capacity for neuronal repair in apoE epsilon4 carriers.

Citing Articles

Association of cardiovascular health with cognitive function and the mediating effect of depressive state.

Hu Y, Sun X, Guo C, Wu R, Dou J, Song S Front Aging Neurosci. 2025; 16:1465310.

PMID: 39744518 PMC: 11688292. DOI: 10.3389/fnagi.2024.1465310.


Cluster-Based White Matter Signatures and the Risk of Dementia, Stroke, and Mortality in Community-Dwelling Adults.

Rosbergen M, Wolters F, Vinke E, Mattace-Raso F, Roshchupkin G, Ikram M Neurology. 2024; 103(7):e209864.

PMID: 39255426 PMC: 11399066. DOI: 10.1212/WNL.0000000000209864.


Alzheimer's disease genetic risk and changes in brain atrophy and white matter hyperintensities in cognitively unimpaired adults.

Soldan A, Wang J, Pettigrew C, Davatzikos C, Erus G, Hohman T Brain Commun. 2024; 6(5):fcae276.

PMID: 39229494 PMC: 11369827. DOI: 10.1093/braincomms/fcae276.


Not So Transient?: A Narrative Review on Cognitive Impairment After Transient Ischemic Attack.

Hayes A, Kasner S, Favilla C, Rothstein A, Witsch J, Hamilton R Stroke. 2024; 55(10):2558-2566.

PMID: 39212043 PMC: 11421974. DOI: 10.1161/STROKEAHA.124.046821.


-ε4 allele[s]-associated adverse events reported from placebo arm in clinical trials for Alzheimer's disease: implications for anti-amyloid beta therapy.

Sato K, Niimi Y, Ihara R, Suzuki K, Iwata A, Iwatsubo T Front Dement. 2024; 2:1320329.

PMID: 39081988 PMC: 11285649. DOI: 10.3389/frdem.2023.1320329.